Showing 441 - 460 results of 100,062 for search '(( 50 ((((we decrease) OR (a decrease))) OR (nn decrease)) ) OR ( 1 b decrease ))', query time: 1.48s Refine Results
  1. 441
  2. 442
  3. 443

    GLB1 increases expression in HGPIN and a subset of PCa and correlates with decreased proliferation and increased expression of HP1γ. by Jennifer Wagner (523883)

    Published 2015
    “…Primary cancer samples demonstrated increased expression in a subset of samples (nuclear expression shown). <b>(D)</b> The microarrays were immunostained for the proliferation protein Ki67, the heterochromatin protein HP1γ increased in senescence, and p27, a marker decreased in terminal senescence. …”
  4. 444

    Ofd1 protection of photoreceptors from oxidative stress via decreasing ROS production. by Juan Wang (115708)

    Published 2016
    “…Scale bar: 50μm. (B) Cell viability and proliferation detection in 661W cell using the MTT assay. …”
  5. 445

    Image_3_A Shift in Myeloid Cell Phenotype via Down Regulation of Siglec-1 in Island Macrophages of Bone Marrow Is Associated With Decreased Late Erythroblasts Seen in Anemia of Cri... by Shirin Hasan (7894118)

    Published 2019
    “…There were more (2.5-fold) EEBs and less LEBs (2.4-fold) per million TBM cells in B; with a corresponding decrease in Siglec-1 and Ly6G expressions in EBIMØ associated with EEB. …”
  6. 446

    Image_4_A Shift in Myeloid Cell Phenotype via Down Regulation of Siglec-1 in Island Macrophages of Bone Marrow Is Associated With Decreased Late Erythroblasts Seen in Anemia of Cri... by Shirin Hasan (7894118)

    Published 2019
    “…There were more (2.5-fold) EEBs and less LEBs (2.4-fold) per million TBM cells in B; with a corresponding decrease in Siglec-1 and Ly6G expressions in EBIMØ associated with EEB. …”
  7. 447
  8. 448
  9. 449
  10. 450

    S1 Data - by Mahmoud A. Alomari (14780446)

    Published 2023
    “…</p><p>Conclusions</p><p>Changes in the SH during COVID-19 have been reported in about 50% of participants who smoke tobacco, with a more reported decrease than increase in use. …”
  11. 451

    Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma by Zhihao Liu (419349)

    Published 2024
    “…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …”
  12. 452

    Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma by Zhihao Liu (419349)

    Published 2024
    “…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …”
  13. 453

    Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma by Zhihao Liu (419349)

    Published 2024
    “…In our previous study, we have identified a series of type I PRMT inhibitors, among which ZL-28-6 (<b>6</b>) exhibited increased activity against CARM1 while displaying decreased potency against other type I PRMTs. …”
  14. 454
  15. 455
  16. 456
  17. 457
  18. 458
  19. 459
  20. 460